Income Statement Colinz Laboratories Limited

Stocks

COLINZ6

INE923C01011

Pharmaceuticals

Market Closed - Bombay S.E. 13:02:26 03/09/2026 +03			5-day change	1st Jan Change
71.50 ^INR	+2.72%		-4.37%	+33.32%

07-30	Colinz Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
06-18	Annjana Dugar, Likhitta Dugar and Antariksh Dugar executed of Share Purchase Agreement to acquire an additional 34.56% stake in Colinz Laboratories Limited from Vijaya Mani for INR 43.5 million,	CI

c6790106df39c98106b.0uf0iPz2Ynht-CHT2496r_6t6oNgEFfEqJaKwcZ_0nc.44K14Z2xE1Ucyxafl7wj2M6Us-QZQQOW0fHC-ZZLt0OEjYe_lcQwGTXOcA

Published financial data: COLINZ LABORATORIES LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Revenues	69.74M	71.55M	70.3M	65.28M	61.36M
Other Revenues, Total	-	-	-	-	-1K
Total Revenues	69.74M	71.55M	70.3M	65.28M	61.36M
Cost of Goods Sold, Total	23.74M	23.94M	24.46M	21.41M	17.48M
Gross Profit	46.01M	47.61M	45.84M	43.87M	43.88M
Selling General & Admin Expenses, Total	30.34M	32M	31.34M	30.27M	29.42M
Depreciation & Amortization - (IS)	2.01M	1.29M	1.3M	1.31M	1.56M
Other Operating Expenses	9.8M	9.28M	9.08M	8.65M	10.39M
Other Operating Expenses, Total	42.16M	42.57M	41.72M	40.23M	41.37M
Operating Income	3.85M	5.04M	4.12M	3.64M	2.51M
Interest Expense, Total	-755K	-523K	-372K	-424K	-466K
Interest And Investment Income	1.67M	1.7M	2.74M	2.88M	4.84M
Net Interest Expenses	916K	1.18M	2.37M	2.46M	4.38M
Other Non Operating Income (Expenses)	37K	20K	12K	100K	-
EBT, Excl. Unusual Items	4.8M	6.24M	6.5M	6.19M	6.89M
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-	-237K	-	-	-
EBT, Incl. Unusual Items	4.8M	6M	6.5M	6.19M	6.89M
Income Tax Expense	1.41M	1.42M	1.64M	1.23M	1.75M
Earnings From Continuing Operations	3.39M	4.57M	4.87M	4.97M	5.14M
Net Income to Company	3.39M	4.57M	4.87M	4.97M	5.14M
Net Income - (IS)	3.39M	4.57M	4.87M	4.97M	5.14M
Net Income to Common Incl Extra Items	3.39M	4.57M	4.87M	4.97M	5.14M
Net Income to Common Excl. Extra Items	3.39M	4.57M	4.87M	4.97M	5.14M
Per Share Items
Net EPS - Basic	0.74	1.82	1.93	1.97	2.04
Basic EPS - Continuing Operations	0.74	1.82	1.93	1.97	2.04
Basic Weighted Average Shares Outstanding	4.59M	2.51M	2.52M	2.52M	2.52M
Net EPS - Diluted	0.74	1.82	1.93	1.97	2.04
Diluted EPS - Continuing Operations	0.74	1.82	1.93	1.97	2.04
Diluted Weighted Average Shares Outstanding	4.59M	2.51M	2.52M	2.52M	2.52M
Normalized Basic EPS	0.65	1.55	1.61	1.54	1.71
Normalized Diluted EPS	0.65	1.55	1.61	1.54	1.71
Supplemental Items
EBITDA	5.86M	6.33M	5.43M	4.95M	4.08M
EBITA	3.85M	5.04M	4.12M	3.64M	2.51M
EBIT	3.85M	5.04M	4.12M	3.64M	2.51M
EBITDAR	7.06M	7.83M	7.15M	6.66M	6.37M
Total Revenues (As Reported)	71.45M	73.27M	73.05M	68.26M	66.2M
Effective Tax Rate - (Ratio)	29.36	23.74	25.16	19.83	25.34
Total Current Taxes	1.44M	1.58M	1.78M	1.75M	1.9M
Total Deferred Taxes	-97K	-156K	-124K	-522K	-154K
Normalized Net Income	3M	3.9M	4.06M	3.87M	4.31M
Interest on Long-Term Debt	-	-	-	-	-
Non-Cash Pension Expense	471K	293K	165K	433K	1.47M
Supplemental Operating Expense Items
Advertising Expense	114K	157K	111K	178K	166K
Selling and Marketing Expenses	114K	157K	111K	178K	166K
Research And Development Expense From Footnotes	62K	58K	82K	109K	66K
Net Rental Expense, Total	1.2M	1.5M	1.72M	1.71M	2.29M
Imputed Operating Lease Interest Expense	981K	1.66M	1.21M	960K	1.66M
Imputed Operating Lease Depreciation	219K	-156K	506K	753K	635K
Maintenance & Repair Expenses, Total	750K	1.01M	1.32M	504K	379K

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Assets
Cash And Equivalents	20.88M	19.65M	29.47M	24M	7.03M
Short Term Investments	31.18M	37.63M	40.54M	31.5M	78.26M
Total Cash And Short Term Investments	52.06M	57.29M	70M	55.5M	85.29M
Accounts Receivable, Total	12.06M	11.34M	8.59M	6.61M	8.35M
Other Receivables	-	-	-	-	-
Total Receivables	12.06M	11.34M	8.59M	6.61M	8.35M
Inventory	9.25M	9.39M	8.47M	7.81M	7.04M
Prepaid Expenses	-	-	-	-	-
Other Current Assets, Total	416K	336K	290K	20.24M	91K
Total Current Assets	73.79M	78.35M	87.35M	90.16M	101M
Gross Property Plant And Equipment	69.13M	61.74M	61.74M	64.32M	64.32M
Accumulated Depreciation	-50.52M	-44.65M	-45.95M	-47.31M	-48.88M
Net Property Plant And Equipment	18.62M	17.09M	15.79M	17M	15.44M
Long-term Investments	6.69M	6.63M	10.22M	10.44M	11.06M
Loans Receivable Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	213K	234K	235K	560K	541K
Total Assets	99.31M	102M	114M	118M	128M
Liabilities
Accounts Payable, Total	4.75M	6.54M	5.98M	5.43M	3.83M
Accrued Expenses, Total	9.43M	8.99M	9.73M	9.37M	7.35M
Short-term Borrowings	4.84M	2.73M	5.7M	6.41M	3.9M
Current Income Taxes Payable	17K	24K	-	-	-
Other Current Liabilities	775K	571K	415K	415K	10.58M
Total Current Liabilities	19.82M	18.86M	21.82M	21.62M	25.66M
Long-Term Debt	-	-	-	-	-
Deferred Tax Liability Non Current	2.22M	2.06M	2.29M	1.81M	1.73M
Other Non Current Liabilities	407K	-	-	-	-
Total Liabilities	22.44M	20.92M	24.1M	23.43M	27.38M
Common Stock, Total	35.45M	25.19M	25.19M	25.19M	25.19M
Additional Paid In Capital	15.23M	10.1M	10.1M	10.1M	10.1M
Retained Earnings	20.13M	24.7M	29.57M	34.53M	39.68M
Comprehensive Income and Other	6.07M	21.4M	24.63M	24.92M	25.46M
Total Common Equity	76.87M	81.39M	89.49M	94.74M	100M
Total Equity	76.87M	81.39M	89.49M	94.74M	100M
Total Liabilities And Equity	99.31M	102M	114M	118M	128M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	4.57M	2.52M	2.52M	2.52M	2.52M
ECS Total Common Shares Outstanding	4.57M	2.52M	2.52M	2.52M	2.52M
Book Value / Share	16.82	32.31	35.52	37.61	39.87
Tangible Book Value	76.87M	81.39M	89.49M	94.74M	100M
Tangible Book Value Per Share	16.82	32.31	35.52	37.61	39.87
Total Debt	4.84M	2.73M	5.7M	6.41M	3.9M
Net Debt	-47.22M	-54.55M	-64.3M	-49.09M	-81.39M
Debt Equivalent Oper. Leases	9.6M	12M	13.76M	13.7M	18.35M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	1.27M	1.07M	963K	1.12M	498K
Inventories - Finished Goods, Total	7.98M	8.32M	7.51M	6.69M	6.54M
Land - (BS)	2.57M	2.57M	2.57M	2.57M	2.57M
Buildings, Total	30.61M	30.61M	30.61M	30.61M	30.61M
Machinery, Total	35.95M	28.56M	28.56M	31.14M	31.14M
Full Time Employees	64	67	69	65	62

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Net Income	3.39M	4.57M	4.87M	4.97M	5.14M
Depreciation & Amortization - CF	2.01M	1.29M	1.3M	1.31M	1.56M
Depreciation & Amortization, Total	2.01M	1.29M	1.3M	1.31M	1.56M
(Gain) Loss From Sale Of Asset	-	237K	-	-	-
Other Operating Activities, Total	-1.05M	-1.35M	-2.49M	-3.31M	-4.53M
Change In Accounts Receivable	918K	719K	2.75M	1.98M	-1.74M
Change In Inventories	3.21M	-135K	919K	660K	774K
Change In Accounts Payable	-690K	1.79M	-568K	-545K	-1.6M
Change in Other Net Operating Assets	-3.12M	-3.09M	3.57M	-19.6M	25.81M
Cash from Operations	4.67M	4.03M	10.35M	-14.54M	25.41M
Capital Expenditure	-375K	-	-	-2.62M	-
Investment in Marketable and Equity Securities, Total	-	-	-	192K	-
Other Investing Activities, Total	50K	87K	69K	84K	113K
Cash from Investing	-325K	87K	69K	-2.34M	113K
Long-Term Debt Repaid, Total	-	-	-	-	-
Total Debt Repaid	-	-	-	-	-
Other Financing Activities, Total	903K	1.11M	2.3M	2.38M	4.27M
Cash from Financing	903K	1.11M	2.3M	2.38M	4.27M
Net Change in Cash	5.25M	5.23M	12.71M	-14.5M	29.79M
Supplemental Items
Cash Interest Paid	755K	523K	372K	424K	466K
Cash Income Tax Paid (Refund)	1.51M	1.58M	1.76M	2.08M	1.9M
Levered Free Cash Flow	6.81M	5.93M	7.35M	-17.51M	28.57M
Unlevered Free Cash Flow	7.28M	6.26M	7.59M	-17.25M	28.86M
Change In Net Working Capital	-3.24M	-1.82M	-3.7M	18.21M	-25.73M
Net Debt Issued / Repaid	-	-	-	-	-

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Profitability
Return on Assets	2.4	3.12	2.39	1.96	1.28
Return on Total Capital	2.92	3.8	2.88	2.32	1.53
Return On Equity %	4.53	5.78	5.7	5.39	5.27
Return on Common Equity	4.53	5.78	5.7	5.39	5.27
Margin Analysis
Gross Profit Margin %	65.97	66.54	65.21	67.21	71.51
SG&A Margin	43.51	44.72	44.58	46.38	47.94
EBITDA Margin %	8.41	8.84	7.72	7.58	6.64
EBITA Margin %	5.52	7.04	5.87	5.57	4.09
EBIT Margin %	5.52	7.04	5.87	5.57	4.09
Income From Continuing Operations Margin %	4.86	6.39	6.92	7.61	8.38
Net Income Margin %	4.86	6.39	6.92	7.61	8.38
Net Avail. For Common Margin %	4.86	6.39	6.92	7.61	8.38
Normalized Net Income Margin	4.3	5.45	5.78	5.93	7.02
Levered Free Cash Flow Margin	9.77	8.29	10.46	-26.83	46.56
Unlevered Free Cash Flow Margin	10.44	8.75	10.79	-26.42	47.03
Asset Turnover
Asset Turnover	0.7	0.71	0.65	0.56	0.5
Fixed Assets Turnover	3.59	4.01	4.28	3.98	3.78
Receivables Turnover (Average Receivables)	5.57	6.12	7.05	8.59	8.2
Inventory Turnover (Average Inventory)	2.19	2.57	2.74	2.63	2.36
Short Term Liquidity
Current Ratio	3.72	4.15	4	4.17	3.93
Quick Ratio	3.24	3.64	3.6	2.87	3.65
Operating Cash Flow to Current Liabilities	0.24	0.21	0.47	-0.67	0.99
Days Sales Outstanding (Average Receivables)	65.51	59.69	51.89	42.5	44.49
Days Outstanding Inventory (Average Inventory)	166.99	142.11	133.63	138.78	154.96
Average Days Payable Outstanding	90.63	85.62	97.35	100.35	101.11
Cash Conversion Cycle (Average Days)	141.87	116.17	88.17	80.93	98.34
Long Term Solvency
Total Debt/Equity	6.3	3.36	6.37	6.76	3.88
Total Debt / Total Capital	5.93	3.25	5.99	6.34	3.74
LT Debt/Equity	-	-	-	-	-
Long-Term Debt / Total Capital	-	-	-	-	-
Total Liabilities / Total Assets	22.6	20.44	21.22	19.83	21.42
EBIT / Interest Expense	5.1	9.63	11.09	8.58	5.39
EBITDA / Interest Expense	7.76	12.1	14.59	11.68	8.74
(EBITDA - Capex) / Interest Expense	7.27	12.1	14.59	5.5	8.74
Total Debt / EBITDA	0.83	0.43	1.05	1.29	0.96
Net Debt / EBITDA	-8.05	-8.62	-11.85	-9.92	-19.97
Total Debt / (EBITDA - Capex)	0.88	0.43	1.05	2.75	0.96
Net Debt / (EBITDA - Capex)	-8.61	-8.62	-11.85	-21.05	-19.97
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	13.24	2.59	-1.75	-7.14	-6
Gross Profit, 1 Yr. Growth %	17.07	3.48	-3.72	-4.3	0.02
EBITDA, 1 Yr. Growth %	75.93	7.92	-14.2	-8.79	-17.69
EBITA, 1 Yr. Growth %	171.32	30.83	-18.11	-11.78	-30.97
EBIT, 1 Yr. Growth %	171.32	30.83	-18.11	-11.78	-30.97
Earnings From Cont. Operations, 1 Yr. Growth %	63.44	34.81	6.41	2.03	3.6
Net Income, 1 Yr. Growth %	63.44	34.81	6.41	2.03	3.6
Normalized Net Income, 1 Yr. Growth %	95.88	29.81	4.3	-4.75	11.25
Diluted EPS Before Extra, 1 Yr. Growth %	64.44	145.95	6.04	2.07	3.55
Accounts Receivable, 1 Yr. Growth %	-7.07	-5.95	-24.24	-23.08	26.36
Inventory, 1 Yr. Growth %	-25.77	1.46	-9.79	-7.79	-9.91
Net Property, Plant and Equip., 1 Yr. Growth %	-8.08	-8.2	-7.62	7.7	-9.19
Total Assets, 1 Yr. Growth %	-1.69	3.01	11.03	4.03	8.16
Tangible Book Value, 1 Yr. Growth %	5.43	5.88	9.95	5.87	6
Common Equity, 1 Yr. Growth %	5.43	5.88	9.95	5.87	6
Cash From Operations, 1 Yr. Growth %	-78.36	-13.74	156.81	-240.48	-274.8
Capital Expenditures, 1 Yr. Growth %	-76.25	-	-	-	-
Levered Free Cash Flow, 1 Yr. Growth %	-37.32	-12.94	23.98	-338.17	-263.14
Unlevered Free Cash Flow, 1 Yr. Growth %	-36.16	-14.09	21.22	-327.37	-267.34
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-4.23	7.78	0.4	-4.48	-6.57
Gross Profit, 2 Yr. CAGR %	-2.31	10.07	-0.18	-4.01	-2.16
EBITDA, 2 Yr. CAGR %	39.15	37.79	-3.77	-11.53	-13.36
EBITA, 2 Yr. CAGR %	88.86	88.41	3.51	-15	-21.96
EBIT, 2 Yr. CAGR %	88.86	88.41	3.51	-15	-21.96
Earnings From Cont. Operations, 2 Yr. CAGR %	61.28	48.43	19.77	4.2	2.82
Net Income, 2 Yr. CAGR %	61.28	48.43	19.77	4.2	2.82
Normalized Net Income, 2 Yr. CAGR %	65.17	59.46	16.36	-0.33	2.94
Diluted EPS Before Extra, 2 Yr. CAGR %	61.03	101.11	61.5	4.04	2.81
Accounts Receivable, 2 Yr. CAGR %	-10.07	-6.52	-15.59	-23.66	-1.41
Inventory, 2 Yr. CAGR %	-26.03	-13.22	-4.33	-8.8	-8.86
Net Property, Plant and Equip., 2 Yr. CAGR %	-4.91	-8.14	-7.91	-0.25	-1.1
Total Assets, 2 Yr. CAGR %	6.17	0.63	6.95	7.47	6.08
Tangible Book Value, 2 Yr. CAGR %	6.03	5.65	7.89	7.89	5.94
Common Equity, 2 Yr. CAGR %	6.03	5.65	7.89	7.89	5.94
Cash From Operations, 2 Yr. CAGR %	-10.3	-56.79	48.83	89.95	56.7
Capital Expenditures, 2 Yr. CAGR %	-7.42	-	-	-	-
Levered Free Cash Flow, 2 Yr. CAGR %	-1.02	-26.13	3.9	71.84	97.12
Unlevered Free Cash Flow, 2 Yr. CAGR %	-0.59	-25.94	2.05	66.02	95.06
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-3.11	-2.01	4.51	-2.18	-4.99
Gross Profit, 3 Yr. CAGR %	-1.59	-0.41	5.27	-1.57	-2.68
EBITDA, 3 Yr. CAGR %	18.68	27.85	17.66	-5.47	-13.64
EBITA, 3 Yr. CAGR %	41.89	67.11	42.72	-1.86	-20.7
EBIT, 3 Yr. CAGR %	41.89	67.11	42.72	-1.86	-20.7
Earnings From Cont. Operations, 3 Yr. CAGR %	40.73	51.92	32.84	13.54	4
Net Income, 3 Yr. CAGR %	40.73	51.92	32.84	13.54	4
Normalized Net Income, 3 Yr. CAGR %	45.56	52.42	38.42	8.85	3.39
Diluted EPS Before Extra, 3 Yr. CAGR %	54.67	85.45	62.47	38.59	3.88
Accounts Receivable, 3 Yr. CAGR %	-10.42	-8.72	-12.84	-18.16	-9.7
Inventory, 3 Yr. CAGR %	-21.3	-17.81	-12.09	-5.5	-9.17
Net Property, Plant and Equip., 3 Yr. CAGR %	-5.56	-6.02	-7.97	-2.98	-3.33
Total Assets, 3 Yr. CAGR %	2.68	5.11	3.99	5.97	7.7
Tangible Book Value, 3 Yr. CAGR %	3.96	5.98	7.07	7.22	7.26
Common Equity, 3 Yr. CAGR %	3.96	5.98	7.07	7.22	7.26
Cash From Operations, 3 Yr. CAGR %	59.08	-11.47	-21.73	46	84.76
Capital Expenditures, 3 Yr. CAGR %	-	-	-	91.15	-
Levered Free Cash Flow, 3 Yr. CAGR %	29.15	-5.16	-12.21	36.99	68.89
Unlevered Free Cash Flow, 3 Yr. CAGR %	41.82	-5.31	-12.72	33.29	66.46
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-1.8	-1.92	-1.72	-3	-0.07
Gross Profit, 5 Yr. CAGR %	-1.83	-1.79	-1.03	-1.87	2.23
EBITDA, 5 Yr. CAGR %	7.45	12.02	9.13	10.34	4.11
EBITA, 5 Yr. CAGR %	21.69	29.64	25.07	27.52	12.1
EBIT, 5 Yr. CAGR %	21.69	29.64	25.07	27.52	12.1
Earnings From Cont. Operations, 5 Yr. CAGR %	19.18	14.67	31.94	30.65	19.9
Net Income, 5 Yr. CAGR %	19.18	14.67	31.94	30.65	19.9
Normalized Net Income, 5 Yr. CAGR %	32.39	32.74	33.09	28.61	22.96
Diluted EPS Before Extra, 5 Yr. CAGR %	18.86	29.49	57.36	47.17	35.3
Accounts Receivable, 5 Yr. CAGR %	-3.85	-7.59	-12.53	-15.02	-8.44
Inventory, 5 Yr. CAGR %	-15.6	-13.76	-14.91	-14.32	-10.81
Net Property, Plant and Equip., 5 Yr. CAGR %	-6.7	-6.66	-6.5	-3.75	-5.28
Total Assets, 5 Yr. CAGR %	0.52	1.3	4.36	6.05	4.82
Tangible Book Value, 5 Yr. CAGR %	3.34	3.81	5.51	6.74	6.61
Common Equity, 5 Yr. CAGR %	3.34	3.81	5.51	6.74	6.61
Cash From Operations, 5 Yr. CAGR %	52.29	3.66	54.9	20.15	3.32
Capital Expenditures, 5 Yr. CAGR %	16.99	-	-	43.03	-
Levered Free Cash Flow, 5 Yr. CAGR %	32.84	-0.25	18.38	20.29	21.33
Unlevered Free Cash Flow, 5 Yr. CAGR %	25.03	-0.85	24.33	18.54	20.4